Correlation Between Integrated Biopharma and Uniroyal Global

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Integrated Biopharma and Uniroyal Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Integrated Biopharma and Uniroyal Global into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Integrated Biopharma and Uniroyal Global Engineered, you can compare the effects of market volatilities on Integrated Biopharma and Uniroyal Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Integrated Biopharma with a short position of Uniroyal Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of Integrated Biopharma and Uniroyal Global.

Diversification Opportunities for Integrated Biopharma and Uniroyal Global

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Integrated and Uniroyal is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Integrated Biopharma and Uniroyal Global Engineered in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uniroyal Global Engi and Integrated Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Integrated Biopharma are associated (or correlated) with Uniroyal Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uniroyal Global Engi has no effect on the direction of Integrated Biopharma i.e., Integrated Biopharma and Uniroyal Global go up and down completely randomly.

Pair Corralation between Integrated Biopharma and Uniroyal Global

If you would invest (100.00) in Integrated Biopharma on December 2, 2024 and sell it today you would earn a total of  100.00  from holding Integrated Biopharma or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Integrated Biopharma  vs.  Uniroyal Global Engineered

 Performance 
       Timeline  
Integrated Biopharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Uniroyal Global Engi 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Uniroyal Global Engineered are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak forward indicators, Uniroyal Global reported solid returns over the last few months and may actually be approaching a breakup point.

Integrated Biopharma and Uniroyal Global Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Integrated Biopharma and Uniroyal Global

The main advantage of trading using opposite Integrated Biopharma and Uniroyal Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Integrated Biopharma position performs unexpectedly, Uniroyal Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uniroyal Global will offset losses from the drop in Uniroyal Global's long position.
The idea behind Integrated Biopharma and Uniroyal Global Engineered pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities